In addition, serum CDO1 hypermethylation was correlated significantly with the advanced T stage, the advanced N stage, metastasis, the TNM stage, HER2 status and molecular phenotypes in the cohort II of 113 BC patients (p < .05) (Supporting Information Table [Link], [Link], Figure 8D–I). This evidence concerns the gene ERBB2 and breast cancer.